ReportWire

Tag: Marijuana

  • Denmark And Cannabis

    [ad_1]

    Cannabis and Denmark collide as culture, health policy, alcohol use, and happiness shape the country’s evolving cannabis debate.

    Denmark, the Danish Royal Family and Greenland have been in the news. This leaves us wondering, what about Denmark and cannabis? The country’s relationship with cannabis sits at the intersection of tradition, public health, and an evolving cultural conversation about substances, happiness, and social responsibility. While the country is often seen as progressive, cannabis remains illegal for recreational use, even as public debate and medical acceptance continue to grow.

    Related: What’s Up With Happy Finland And Marijuana

    Under Danish law, recreational cannabis is prohibited, and possession can result in fines or legal penalties. In practice, however, enforcement is generally measured. Small amounts intended for personal use often lead to warnings or modest fines rather than severe punishment. Despite its illegal status, cannabis is the most commonly used illicit substance in Denmark. Health authorities estimate roughly one in ten Danes aged 16 to 44 report recent cannabis use, reflecting a level of normalization in everyday life even without legalization.

    The Danish Royal Family

    Denmark has taken a more formal step forward with medical cannabis. In 2018, the government introduced a national medical cannabis pilot program, allowing doctors to prescribe cannabis-based products for conditions such as chronic pain, multiple sclerosis, and chemotherapy-related symptoms. The program has since been extended and broadened, signaling institutional recognition cannabis can have therapeutic value when regulated and medically supervised.

    Alcohol, meanwhile, has long been deeply woven into Danish culture. Denmark consistently ranks among Europe’s highest consumers of alcohol, particularly when it comes to binge drinking. Social drinking is common across generations, and alcohol is widely available and socially accepted. But like the United States, recent studies suggest changing attitudes among younger Danes, with declining rates of both alcohol and cannabis use among teens and young adults. Public health campaigns, wellness trends, and shifting social norms appear to be influencing these behaviors.

    These substance use patterns exist alongside Denmark’s global reputation for happiness. According to the World Happiness Report, Denmark routinely ranks in the top three happiest countries in the world. Factors contributing to this ranking include strong social trust, universal healthcare, work-life balance, economic security, and a high degree of confidence in public institutions. The country’s happiness score typically sits around 7.5 out of 10, well above the global average.

    RELATED: Science Says Medical Marijuana Improves Quality Of Life

    An often-overlooked influence on Danish cultural norms is the Danish royal family. The monarchy, while largely ceremonial, plays a powerful symbolic role in shaping national identity. The royal family is widely respected and known for its emphasis on stability, duty, and social cohesion. Members of the monarchy tend to avoid political controversy, including debates around cannabis or drug policy, instead focusing on public service, health initiatives, environmental causes, and cultural unity. Their restrained and disciplined public image reinforces Denmark’s broader cultural preference for moderation and responsibility, even as society debates reform in areas like cannabis regulation.

    In many ways, Denmark’s cannabis conversation mirrors the nation itself: pragmatic, cautious, and grounded in public welfare rather than ideology. While full legalization remains off the table for now, medical access, shifting attitudes, and open debate suggest Denmark’s approach will continue to evolve. Set against a backdrop of high alcohol use, declining youth consumption, a respected monarchy, and one of the happiest populations on Earth, cannabis in Denmark is less about rebellion and more about how a stable society manages change.

    [ad_2]

    Anthony Washington

    Source link

  • The Rebel Heart Of The South Includes Cannabis And Rock

    [ad_1]

    Southern rock, outlaw spirit, and reform meet as the rebel heart of the South includes cannabis and rock in today’s cultural landscape.

    In the American South, where music and culture entwine like the roots of an old oak, the intersection of cannabis and Southern-flavored rock sounds is more than a footnote — it’s a story of rebellion, identity, and evolving norms mirroring broader societal shifts. Southern rock, born in the 1960s and 1970s, has always been about defying expectations: guitars blazing, rhythms throbbing, and lyrics steeped in regional pride. Bands like Lynyrd Skynyrd helped define sounds with tracks like “Sweet Home Alabama” and “Free Bird,” songs which became anthems of a generation and symbols of Southern resilience and swagger. In today’s word, it is often overlooked the rebel heart of the South includes cannabis and rock and roll.

    RELATED: CBD, Intermittent Fasting And Weight Loss

    Cannabis, too, has carved its own path through Southern culture, once a taboo subject whispered about in honky-tonks and around campfires, now emerging — quietly but steadily — from the shadows of prohibition. As attitudes toward marijuana reform have softened nationwide, the South’s relationship with cannabis has evolved in fits and starts, shaped by economic potential, medical need, and cultural change. States like Mississippi and Louisiana have implemented medical cannabis programs which are expanding access and normalizing patient use in cities like Jackson and New Orleans, while police departments are increasingly de-emphasizing low-level possession enforcement.

    The intertwining of cannabis and Southern rock culture isn’t just about policy; it’s about the artists and the communities they reflect and influence public perception. While Lynyrd Skynyrd didn’t write songs explicitly about cannabis, their rebel image and broader rock’n’roll ethos fit comfortably with countercultural themes that have long included marijuana. Rock musicians across genres have been associated with cannabis use — a cultural touchpoint underscoring music’s role in challenging norms and fostering community. Even Skynyrd’s members have been light-heartedly linked to cannabis culture in anecdotes about informal celebrations with other artists in states where pot is legal.

    Another strand in this tapestry is the enduring legacy of outlaw and rockabilly-infused songs like “I Fought the Law.”Written by Sonny Curtis in 1958 and popularized by the Bobby Fuller Four, the track became an anthem of defiance — its refrain “I fought the law and the law won” a mantra for generations of listeners who felt pulled between authority and autonomy. Though not directly about marijuana, the song’s spirit of rebellion resonates strongly with cannabis culture’s own narrative of challenging prohibitionist laws. “I Fought the Law” went on to be covered by artists across genres, from punk icons like The Clash to country stars like Hank Williams Jr., proving how a simple rock ‘n’ roll riff can echo across decades and movements. ZZ Top, The Allman Brothers, The Charlie Daniels Band all draw audiences who feel a bit of rebel in their heart.

    RELATED: Your Zodiac Sign And Marijuana

    Culturally, the South has been slower than other regions to embrace full recreational cannabis legalization, but the tide is shifting. Missouri stands out in the wider Southern region for legalizing adult-use cannabis, with retail sales beginning in early 2023 and a thriving market taking shape. Other Southern states are making incremental progress: Florida’s robust medical cannabis system continues to grow and saw a recent push for adult-use nearly passed, while Mississippi, Louisiana, and Arkansas have medical programs reflecting gradual reform. However, many states — including Texas, Georgia, South Carolina, and Tennessee — remain more restrictive, embracing only limited medical access or hemp-derived products.

    What’s clear is the intersection of cannabis and Southern rock mirrors broader cultural currents: a blend of tradition, resistance, and reinvention. As Southern states grapple with changing public opinion and economic incentives, the region’s music and cannabis cultures continue to influence each other, proving that even in the South, transformation moves to its own rhythm — but it moves.

    [ad_2]

    Anthony Washington

    Source link

  • Will Cannabis Be At The California Super Bowl

    [ad_1]

    Will cannabis be at the California Super Bowl as gummies quietly rival beer at America’s biggest game

    As the state prepares to host, a familiar question is quietly circulating alongside conversations about commercials, halftime performers, and watch parties: will cannabis be at the California Super Bowl, the biggest sporting event in America?

    California has long been a pioneer in cannabis legalization and normalization. From the passage of medical marijuana laws in the 1990s to full adult-use legalization in 2016, the state helped transform cannabis from a taboo substance into a regulated, mainstream consumer product. Today, legal dispensaries operate across California, cannabis brands advertise on billboards and podcasts, and infused products are as familiar to many adults as craft beer or fine wine.

    RELATED: Sara Carter Bailey Approved For New Drug Czar

    Yet the Super Bowl remains a complicated space for cannabis. The game itself is governed by the non-profit NFL and broadcast standards still prohibit cannabis advertising and on-site consumption, even in fully legal states. Inside the stadium, cannabis will not be sold, promoted, or consumed legally, despite California law allowing adult use elsewhere.  Some guests might bring in edibles, but even tobacco vapes are banned. Alcohol, however, will once again dominate. Beer sponsorships, liquor ads, and branded cocktails are a staple of Super Bowl culture, both in the stands and in living rooms across the country.

    At home, the contrast is even sharper. Super Bowl Sunday has become one of the biggest alcohol consumption days of the year in the United States. Viewers are encouraged to drink early, drink often, and associate the game with beer runs and party coolers. In California, however, a growing number of adults are choosing cannabis as an alternative. This shift is subtle, but real, particularly among consumers looking to avoid hangovers, reduce calories, or simply enjoy a different kind of social experience.

    If cannabis does make an appearance connected to the Super Bowl, gummies are the most likely form. Gummies are by far the most popular edible category in legal markets, favored for their discretion, precise dosing, and lack of smoke or smell. Unlike flower or vapes, gummies can be consumed quietly at home without disrupting guests or drawing attention. For many California viewers, a low-dose gummy has become the equivalent of a beer or glass of wine during the game.

    RELATED: Greenland And Cannabis

    Brands know this, even if they cannot advertise directly. In the days leading up to the Super Bowl, dispensaries often see increased sales, with consumers planning their game-day experiences just as carefully as their snack menus. While cannabis won’t appear in commercials or on the field, it may still be part of Super Bowl Sunday rituals across California.

    So will cannabis be at the California Super Bowl? Not officially, and not visibly. But in living rooms, backyard watch parties, and quiet moments between plays, cannabis, especially gummies, is likely to be part of how many Californians experience the biggest game of the year.

    [ad_2]

    Anthony Washington

    Source link

  • DC’s closure of 100th illegal marijuana operation marks milestone for city’s crackdown – WTOP News

    [ad_1]

    On Jan. 1, 2026, the Alcoholic Beverage and Cannabis Administration (ABCA) and the MPD shut down an illegal cannabis operation at a home on B Street SE, marking the 100th closure over the past 16 months.

    For more than a year D.C. has been targeting illegal cannabis operations in the city. Now, the city has announced the closure of the District’s 100th illegal cannabis business since enforcement actions began in September 2024.

    On Jan. 1, 2026, the Alcoholic Beverage and Cannabis Administration (ABCA) and the Metropolitan Police Department (MPD) shut down an illegal cannabis operation at a home on B Street SE, according to a news release, marking the 100th closure.

    “This is about keeping our community safe and healthy,” Mayor Bowser said in the release. “We have a legal medical cannabis market – that is the market where eligible people should be buying and selling medical cannabis. As we mark this 100th closure, I’m grateful for the steady work of our enforcement teams, and now the work continues.”

    Over the past 15 months, the District has seized more than 700 lbs. of marijuana and 6,300 lbs. of THC edibles. Law enforcement also captured more than 3,000 lbs. of THC lotions and made 56 arrests so far.

    The Metropolitan Police Department add they have seized 12 guns in this operation so far, which is significant because these shops can be “drivers” of violence in the city.

    In the recent closure on B Street SE, police arrested three people and seized a 9mm rifle, a 12-gauge shotgun, and 114 rounds of ammunition.

    [ad_2]

    Kyle Cooper

    Source link

  • Can Cannabis Make 2026 the Best Year Yet

    [ad_1]

    Discover how cannabis make 2026 the best year yet for wellness, balance, fitness, sleep, and mindful living.

    As 2026 unfolds, cannabis is rapidly moving from fringe to frontline in health, wellness, and even mainstream culture. With shifting public opinion, expanding research, and potential federal policy changes looming, many are asking: Can cannabis make 2026 the best year yet? The green plant delivers on its promise — for medicine, lifestyle, and society at large.

    One major reason for optimism is the growing possibility of federal rescheduling. Moving cannabis from Schedule I to Schedule III under the Controlled Substances Act would mark a historic shift. While not full legalization, rescheduling would acknowledge medical value, expand research opportunities, and reduce barriers for doctors, scientists, and legitimate businesses. Even the discussion itself signals how far public policy has evolved, and 2026 could be the year the progress becomes official.

    RELATED: Sara Carter Bailey Approved For New Drug Czar

    The progress is already visible in medicine. Across the country, healthcare providers are increasingly open to cannabis as a complementary therapy. Medical cannabis is now commonly discussed in the context of chronic pain, cancer-related symptoms, neurological conditions, and inflammatory disorders. Patients report benefits for pain management, appetite stimulation during cancer treatment, and relief from nausea and muscle spasms. Importantly, many doctors view cannabis as a potential alternative or adjunct to opioids and other medications with more severe side effects, especially when used thoughtfully and under medical guidance.

    Mental health is another area where cannabis plays a growing role, particularly for younger adults. Anxiety rates among Gen Z have risen sharply, driven by economic stress, social media pressure, and a nonstop digital environment. Rather than heavy intoxication, many in this generation are turning to microdosing cannabis. Low doses of THC or balanced THC-CBD products are used to take the edge off anxiety without impairing focus or motivation. This measured approach reflects a broader trend toward intentional, mindful consumption rather than excess.

    Sleep, often called the foundation of good health, is another reason cannabis is gaining attention. Many adults struggle with insomnia or restless sleep, and cannabis, particularly products with calming terpenes or higher CBD content, is increasingly used as part of nighttime routines. Better sleep can ripple outward, improving mood, productivity, and overall resilience. Similarly, cannabis is being discussed more openly in the context of intimacy, where it may help some people relax, enhance sensory awareness, and reduce anxiety around connection and performance.

    RELATED: The Return of Nostalgic Snacks

    Perhaps most surprising to skeptics is cannabis’s role in healthier lifestyle changes. As more people reassess their relationship with alcohol, cannabis has emerged as a substitute rather than an addition. Many report drinking less when cannabis is available, leading to fewer hangovers, better sleep, and improved workouts. Certain strains and products are also used before exercise to increase focus, enjoyment, and mind-body awareness. Combined with reduced alcohol intake, these shifts may support weight management and more consistent fitness habits.

    Cannabis is not a cure-all, and responsible use matters. But as policy evolves, research expands, and social attitudes mature, cannabis is increasingly seen as a tool rather than a taboo. For millions of Americans, 2026 may be the year cannabis moves fully into the mainstream of health, balance, and intentional living, helping make it one of the best years yet.

    [ad_2]

    Sarah Johns

    Source link

  • First Week of 2026 Sets High Stakes for Cannabis

    [ad_1]

    The first week of 2026 sets high stakes for cannabis as Congress, the White House, and regulators clash. 

    Congress is back in session and the first week of 2026 sets high stakes for cannabis. DC has delivered a series of consequential developments for the industry, highlighting growing momentum for reform alongside persistent resistance in Washington which could shape the sector’s trajectory throughout 2026. On Capitol Hill, the U.S. House of Representatives moved quickly to pass an appropriations measure to continue long-standing protections for state medical marijuana programs. The bill maintains language barring the Department of Justice from interfering with state-legal medical cannabis systems, a provision which has been renewed annually for nearly a decade. Notably, the House rejected an effort to include language that would have blocked the federal government from rescheduling marijuana under the Controlled Substances Act.

    RELATED: Sara Carter Bailey Approved For New Drug Czar

    The House vote was seen as a significant signal to the cannabis industry, which has closely watched congressional maneuvering over federal reform. By allowing the spending bill to advance without restrictions on rescheduling, lawmakers effectively cleared one procedural obstacle to a change that could have sweeping financial and regulatory consequences for cannabis businesses nationwide. The measure now heads to the Senate, where similar provisions have historically received bipartisan support.

    These legislative developments come as the executive branch continues to press forward with plans to reschedule marijuana. In late December, President Donald Trump issued an executive order directing the Department of Justice to move marijuana from Schedule I to Schedule III, a classification which would formally recognize its medical use and significantly reduce the tax burden on state-legal cannabis operators by easing Internal Revenue Code Section 280E restrictions.

    Despite the executive order, progress has been uneven. House Speaker Mike Johnson of Louisiana has publicly expressed opposition to rescheduling, raising concerns about public health and warning against moving too quickly on cannabis reform. His resistance reflects broader divisions within Congress, particularly among conservative lawmakers who remain skeptical of federal marijuana policy changes even as public support for legalization continues to grow.

    Adding to the uncertainty, the Drug Enforcement Administration has indicated it will follow standard administrative procedures before implementing any rescheduling decision. While the White House has called for expedited action, industry observers say the DEA’s internal review process could slow the timeline, potentially pushing final implementation well into the year.

    RELATED: Greenland And Cannabis

    Beyond marijuana itself, federal attention has also turned to hemp and hemp-derived products. Regulatory scrutiny of intoxicating hemp compounds, including delta-8 and similar cannabinoids, remains intense as lawmakers and federal agencies debate tighter limits on THC content and clearer enforcement standards. While recent executive actions did not directly alter existing hemp law, companies across the sector are preparing for potential changes later this year potentially reshaping the rapidly growing hemp marketplace.

    Taken together, the opening days of 2026 underscore a cannabis industry navigating a complex policy environment. Congressional support for medical marijuana protections, executive pressure to advance rescheduling, leadership opposition in the House, and unresolved questions around hemp regulation have combined to create a moment of high stakes and mixed signals. How these forces resolve in the coming months will have lasting implications for patients, consumers, investors, and businesses across the United States.

    [ad_2]

    Terry Hacienda

    Source link

  • Sara Carter Bailey Approved For New Drug Czar

    [ad_1]

    Sara Carter Bailey approved for new drug czar as cannabis rescheduling debates grow amid strong public support and political resistance.

    The U.S. cannabis industry stands at an inflection point as federal policy debates over rescheduling marijuana intensify. After decades of cannabis being listed as a Schedule I controlled substance — the federal designation reserved for drugs deemed to have no accepted medical use and a high potential for abuse — recent actions by the executive branch have signaled a willingness to reconsider the status. In 2025, the current president  signed an executive order aimed at expediting the rescheduling of cannabis, potentially from Schedule I to Schedule III, a move acknowledging its medical use and ease research and regulatory burdens which have long hampered the industry. This shift has been buoyed by strong public support: polls consistently show a majority of Americans favor federal cannabis reform, even as some political leaders, including House Speaker Mike Johnson, have expressed resistance to broader legalization efforts. Federal rescheduling has become a flashpoint in the ongoing debate about drug policy and states’ rights. And to add something to the mix, Sara Carter Bailey approved for new drug czar, adding another  level of unknown.

    RELATED: 5 Ways Microdosing Cannabis Can Boost Work Performance

    The U.S. Senate confirmed Bailey on 6 January 2026, as the new Director of the White House Office of National Drug Control Policy (ONDCP), often referred to as the federal “drug czar,” in a 52–48 vote. Her appointment comes at a consequential juncture for national drug policy, including cannabis reform. Bailey’s confirmation marks the first time a woman has led the ONDCP, placing her at the center of efforts to shape how the federal government approaches both illicit substances and regulated medical drugs.

    Bailey’s background is unconventional for the post. She built her career as an investigative journalist, covering drug trafficking, national security, and cartel operations, including time as a contributor to national news outlets. She has never before held public office, nor does she have formal training in public health, law enforcement, or drug policy — a point which drew scrutiny from some senators during her confirmation process. Critics questioned her qualifications, while supporters highlighted her on-the-ground reporting experience and understanding of the complex landscape of illegal narcotics.

    On issues directly affecting the cannabis industry, Bailey has left a mix of signals. During her confirmation hearing, she described cannabis rescheduling as a “bipartisan issue” and emphasized federal policy should be informed by “research and data” as the administration evaluates next steps. She also acknowledged past public comments supporting medical cannabis, saying she does not “have any problem if it’s legalized and monitored,” particularly for therapeutic use. However, as the incoming head of ONDCP, she has stopped short of advocating specific policy changes, noting her role requires compliance with existing federal law and collaboration with interagency partners.

    RELATED: There’s No Known Cure For Arthritis, But Marijuana Works Wonders

    Industry observers and advocates will be watching closely to see how Bailey’s tenure influences the cannabis sector. Rescheduling to Schedule III could remove significant legal and financial obstacles for medical cannabis businesses, including access to banking services and federal research opportunities. As ONDCP director, Bailey can play a key role in advising the president and shaping the interagency strategy on drug scheduling, public health education, and enforcement — all of which could either accelerate or complicate the pace of federal cannabis reform. Her path forward will require balancing statutory responsibilities with the growing momentum for change among lawmakers, industry stakeholders, and the public.

    [ad_2]

    Terry Hacienda

    Source link

  • 3 Practical Ways to Lose Weight That Actually Work Including Cannabis

    [ad_1]

    Learn 3 practical ways to lose weight that actually work including cannabis, focusing on sustainable habits, metabolism, and real-life results.

    Losing weight doesn’t require extreme diets, expensive programs, or punishing workout schedules. For most people, the smartest goal is steady, sustainable fat loss—about 1 to 2 pounds per week, which is exactly what most doctors and nutrition experts recommend. Over a month, it adds up to meaningful progress without wrecking your metabolism or daily life.

    Here are 3 practical ways to lose weight that actually work including cannabis. No special, expensive tricks but, a proven path a regular person drop pounds safely and consistently, with the third approach highlighting how cannabis can be used thoughtfully as part of a modern wellness strategy.

    RELATED: CBD, Intermittent Fasting And Weight Loss

    Weight loss still comes down to one core principle: burning slightly more calories than you consume. The key word is slightly. A daily deficit of 300–500 calories is enough to lose 1–2 pounds per week without triggering intense hunger or fatigue.

    The most practical approach:

    • Focus on protein first (eggs, chicken, fish, beans, Greek yogurt)
    • Build meals around fiber-rich foods like vegetables, oats, and fruit
    • Reduce liquid calories such as soda, sweetened coffee, and alcohol

    Instead of tracking every bite forever, many people succeed by tracking just two weeks per month to recalibrate portion sizes. This alone often creates the needed calorie deficit.

    This approach is simple, flexible, and sustainable for real life.

    Photo by Nastasic/Getty Images

    You don’t need marathon training to lose weight. Consistency beats intensity every time.

    The most effective plan:

    • 30–45 minutes of walking most days of the week
    • 2–3 short strength sessions weekly using bodyweight or light weights
    • Staying active throughout the day—standing, stretching, and moving often

    Walking burns fat efficiently, lowers stress hormones, and is easy to maintain long-term. Strength training preserves muscle mass, which keeps your metabolism higher as you lose weight.

    Together, these habits can burn 1,500–2,500 extra calories per week, enough to support steady fat loss without exhaustion.

    Cannabis may seem like an unlikely weight-loss tool, but research and real-world use suggest it can play a supportive role when used intentionally.

    Many people associate cannabis with overeating, but the reality depends on strain, dosage, and timing.

    Smart cannabis use can help by:

    • Reducing stress and emotional eating
    • Improving sleep quality, which is crucial for fat loss
    • Supporting post-workout recovery and pain management
    • Helping some users regulate appetite more mindfully

    RELATED: Your Zodiac Sign And Marijuana

    Certain strains and cannabinoids, particularly THCV and CBD-dominant products, are associated with appetite control and metabolic balance rather than hunger stimulation.

    The most practical approach:

    • Use low-dose cannabis, not heavy intoxication
    • Avoid late-night use that leads to snacking
    • Pair cannabis with healthy routines like walking, stretching, or meal prep

    For many adults moving away from alcohol, cannabis can also eliminate hundreds of empty calories per week—often enough on its own to trigger weight loss.

    Losing 1–2 pounds per week doesn’t require perfection. It requires small, repeatable habits fitting into daily life.

    Control calories without extremes. Move your body consistently. And when used wisely, cannabis can be part of a balanced, modern approach to weight loss and wellness.

    Sustainable results don’t come from punishment—they come from smart systems working with your body, not against it

    [ad_2]

    Amy Hansen

    Source link

  • Venezuela And Marijuana

    [ad_1]

     A look at marijuana and Venezuela, including international assessments of drug trafficking, domestic cannabis laws, medical use policies, and public opinion.

    The current administration’s seizure of the President and First Lady while taking over of Venezuela has thrust the country into the headlines, especially around drugs and oil. But what is the surprising relationship with Venezuela and marijuana? And there role in the broader context of South America’s illicit drug trade. The country’s actual role is frequently misunderstood. While Venezuela’s geography places it near major drug-producing regions, especially Colombia, recent international assessments suggest its involvement in the global narcotics economy is more limited than commonly portrayed. At the same time, cannabis remains illegal inside Venezuela, with no formal medical marijuana framework and relatively little public debate on legalization.

    RELATED: The Best Cocktails For Holiday Day Drinking

    For decades, Venezuela has been viewed primarily as a transit country rather than a producer of drugs. Its long Caribbean coastline and porous land borders have made it attractive to criminal networks moving cocaine and, to a lesser extent, marijuana out of South America. Marijuana trafficked through Venezuela typically originates in Colombia and is shipped onward to Central America or Caribbean markets. Seizures along border regions and coastal waters have reinforced the country’s reputation as a corridor rather than a source.

    The distinction has gained renewed attention following a recent U.S. government report that concluded Venezuela is not among the world’s major players in drug production or large-scale trafficking. The assessment noted Venezuela has no significant coca cultivation and does not rank as a major producer of marijuana. While isolated trafficking networks continue to operate, the report emphasized Venezuela’s overall role in the international drug trade is smaller than several neighboring countries and far from central on a global scale.

    Within Venezuela itself, marijuana remains strictly prohibited. Recreational use, cultivation, and distribution are illegal under national law. Possession of small amounts may be treated as personal use, but it can still result in legal consequences, including mandatory rehabilitation or criminal penalties, depending on circumstances and judicial discretion. Law enforcement policy has historically focused on deterrence rather than regulation.

    Medical cannabis is also illegal in Venezuela. Unlike many Latin American countries who have introduced tightly controlled medical marijuana programs over the past decade, Venezuela has not adopted legislation allowing cannabis-based treatments. Patients seeking medical cannabis must rely on imported pharmaceuticals which do not contain cannabinoids, or on unregulated alternatives, which remain illegal. Government officials have repeatedly stated cannabis legalization, including for medical purposes, is not currently under consideration.

    RELATED: Upgrade Your Gift Game and Avoid the Lame

    Public opinion on marijuana use in Venezuela is difficult to measure due to limited polling and the country’s restrictive legal environment. There are no large, nationally representative surveys tracking attitudes toward cannabis legalization or medical use. International studies suggest countries with strict prohibition tend to report lower levels of cannabis use, but Venezuela-specific data remains scarce. Cultural attitudes, legal risk, and limited public discussion all contribute to the absence of reliable usage statistics.

    Looking ahead, Venezuela’s cannabis policy appears likely to remain unchanged in the near term. While regional trends point toward broader acceptance of medical marijuana and regulated use elsewhere in Latin America, Venezuela has taken a cautious approach shaped by public security priorities and long-standing drug control laws. As international assessments continue to clarify the country’s limited role in global drug trafficking, future discussion may increasingly focus on domestic health policy and enforcement rather than external perceptions.

    [ad_2]

    Terry Hacienda

    Source link

  • What’s Next for Cannabis in 2026

    [ad_1]

    What’s next for cannabis in 2026 a look at federal policy, medical research, hemp drinks and state action.

    The U.S. cannabis industry enters the new year at a crossroads, shaped by federal policy debates, state-level legislative reviews and growing public acceptance of marijuana as both a consumer product and a medical treatment. While sweeping legalization remains uneven, the year ahead could bring some of the most consequential changes the industry has seen in decades. So what’s next for cannabis in 2026.

    At the center of the national conversation is whether marijuana will be rescheduled under federal law. Currently classified as a Schedule I substance — alongside heroin — cannabis is defined as having no accepted medical use. That designation has long conflicted with state medical programs and emerging scientific research.

    RELATED: Cannabis Can Help PTSD

    Federal agencies are now formally reviewing whether marijuana should be moved to Schedule III, a change would acknowledge medical value and significantly alter how cannabis businesses are taxed and regulated. A rescheduling decision would not legalize marijuana nationwide, but it could ease restrictions on research, improve access to banking services and remove a major tax burden faced by licensed operators.

    While momentum has grown, federal officials have not finalized a decision, making 2026 a critical year to watch for regulatory clarity.

    Photo by Anton Petrus/Getty Images

    Another major issue unfolding in 2026 involves hemp-derived THC beverages, which surged in popularity as alcohol alternatives. These drinks, often sold outside licensed cannabis dispensaries, exist in a gray area created by the 2018 Farm Bill.

    New federal and state proposals aim to redefine what qualifies as legal hemp, potentially restricting or eliminating intoxicating hemp products altogether. Some states are moving to regulate hemp drinks like alcohol, while others are considering outright bans.

    The outcome could reshape the beverage market, impact small hemp businesses and determine whether THC drinks remain widely available or move exclusively into regulated cannabis systems.

    If federal rescheduling moves forward, it is expected to unlock greater medical research funding and streamline approval for clinical trials. For decades, cannabis research has lagged due to regulatory hurdles.

    Medical professionals and researchers are increasingly studying cannabis for its potential benefits in treating or alleviating symptoms related to:

    • Chronic and neuropathic pain
    • Cancer-related nausea and appetite loss
    • Epilepsy and seizure disorders
    • Post-traumatic stress disorder (PTSD)
    • Multiple sclerosis
    • Anxiety and sleep disorders
    • Inflammatory and autoimmune conditions

    More funding could lead to standardized dosing, clearer safety guidelines and wider acceptance within mainstream medicine.

    RELATED: Is Cannabis Now The #1 Sleep Aid

    At the state level, cannabis remains a legislative priority in 2026. Several states are reviewing or carrying over bills related to legalization, medical expansion or criminal justice reform.

    Among those under active consideration are Pennsylvania, North Carolina, South Carolina, Tennessee and Texas, each weighing changes ranging from expanded medical access to reduced penalties for possession. While not all proposals are expected to pass, the continued debate reflects shifting public opinion and political pressure.

    Taken together, 2026 could mark a turning point for cannabis in the United States. Federal rescheduling, tighter hemp regulation, increased medical research and renewed state legislative efforts suggest a slow but steady move toward normalization — even as legal contradictions persist.

    For consumers, patients and policymakers alike, the year ahead will help determine whether cannabis continues its gradual integration into American medicine, commerce and culture — or remains caught between reform and restriction.

    [ad_2]

    Terry Hacienda

    Source link

  • The Best Ways Cannabis Can Make the New Year Awesome

    [ad_1]

    Explore the best ways cannabis can make the new year awesome for calm, fitness, pain relief, and healthier routines.

    The New Year often arrives with a familiar mix of optimism and resolve. People vow to feel better, move more, sleep deeper, and manage stress with greater intention. Increasingly, cannabis is part of the conversation—not as a counterculture indulgence, but as a wellness tool embraced by adults seeking balance, moderation, and healthier alternatives. Here are the best ways cannabis can make the new year awesome.

    RELATED: 5 Ways Microdosing Cannabis Can Boost Work Performance

    Stress management remains a top priority each January, and cannabis is increasingly used to support mental well-being. Certain products are favored for their ability to promote relaxation and emotional balance rather than stimulation. When used responsibly, cannabis may help quiet racing thoughts, ease physical tension, and encourage moments of calm. Many people pair cannabis with mindfulness practices such as meditation, stretching, or journaling to reinforce healthier mental habits.

    Photo by rawpixel.com

    One of the fastest-growing trends in cannabis is microdosing. Rather than consuming enough to feel intoxicated, users take very small amounts designed to deliver subtle benefits. Advocates say microdosing can gently elevate mood, sharpen focus, and take the edge off anxiety without interfering with work or daily responsibilities. For many professionals, it offers a way to stay engaged and productive while still enjoying cannabis’s calming properties.

    Another major lifestyle change gaining momentum is the movement away from alcohol and toward cannabis. As more adults reassess their relationship with drinking, cannabis is emerging as a gentler social and personal alternative. Unlike alcohol, cannabis does not dehydrate the body or disrupt sleep in the same way, and many users report waking up clearer and more refreshed. In social settings, low-dose cannabis can help people relax and connect without the downsides often associated with heavy drinking.

    For medical cannabis patients, the New Year can bring renewed hope for managing chronic conditions. Cannabis is commonly used to help address ongoing pain, inflammation, nerve discomfort, and muscle spasms. By reducing pain levels, medical cannabis may enable better sleep, increased mobility, and improved quality of life. For many, it becomes a key component of maintaining daily function and overall wellness.

    RELATED: 5 Workouts That Pair Perfectly With Weed

    Cannabis is also finding a place in fitness and active lifestyles. Some individuals use small amounts before exercise to improve focus or deepen mind-body awareness, while others turn to cannabis after workouts to support relaxation and recovery. By helping ease muscle soreness or inflammation, cannabis may make it easier for people to stay consistent with movement—an essential factor in long-term fitness success.

    As attitudes continue to evolve, cannabis is increasingly viewed through a lens of intention rather than excess. Used thoughtfully, it can support calm, recovery, and balance—qualities many people prioritize at the start of a new year. For those seeking healthier habits and sustainable change, cannabis may offer a modern tool for making the year ahead not just new, but genuinely better.

    [ad_2]

    Sarah Johns

    Source link

  • Can Cannabis Help With Anger

    [ad_1]

    Can cannabis help with anger explore science stress relief and mindful use in todays tense world.

    Right now, the national mood feels tense. Everyday living costs are stubbornly high, political turmoil dominates headlines, and many people feel society has shifted toward self-interest rather than the greater good. Add constant notifications, long commutes, and financial anxiety, and it’s no surprise anger feels closer to the surface than calm. It can play out in a variety of ways – from Congressman Chris Garten posting beating up Santa (R-IN) to spiking high blood pressure. In moments like these, people look for healthy ways to decompress—and for some adults, cannabis has entered the conversation as a possible tool to help cool hot emotions.

    So, can cannabis help with anger? The short answer: it can help some people feel calmer, but how and why matters.

    RELATED: Cannabis Can Help PTSD

    Anger is often a secondary emotion. Beneath it sit stress, fear, exhaustion, and a sense of lost control. When prices rise faster than paychecks, when political debates feel relentless, and when empathy seems in short supply, the nervous system stays in a constant state of alert. The “always on” stress response primes the body for irritability and short tempers.

    Many adults are not looking to “escape” reality—they’re looking for relief, perspective, and a way to slow their racing thoughts. This is where cannabis, used thoughtfully, may help.

    Rep Garten (R-IN) posted a pic of his beating up Santa Claus

    Cannabis interacts with the body’s endocannabinoid system, which plays a role in mood regulation, stress response, and emotional balance. Certain cannabinoids and terpenes are associated with relaxation and reduced stress, which can indirectly soften anger.

    1. 1. It can reduce stress, the fuel behind anger.
      High stress often turns small annoyances into major blowups. Many people report cannabis helps lower baseline stress, making it easier to respond rather than react.
    2. 2. It encourages mental pause and perspective.
      Anger thrives on speed—fast thoughts, fast judgments, fast words. Cannabis can slow the mental momentum, giving users space to reflect before reacting.
    3. 3. It may relax the body, not just the mind.
      Tension in the shoulders, jaw, and chest often accompanies anger. Cannabis is known for its muscle-relaxing effects, which can help break the physical feedback loop keeping anger alive.
    4. 4. It can support better sleep.
      Poor sleep and anger are closely linked. When people are exhausted, emotional regulation drops. For some adults, cannabis supports more restful sleep, which can translate into a calmer mood the next day.

    Not all cannabis experiences are calming. High doses of THC, especially for inexperienced users, can increase anxiety or irritability. Many people seeking emotional balance gravitate toward lower-THC products or strains known for soothing terpene profiles such as myrcene or linalool.

    Microdosing—using just enough to feel relaxed without feeling impaired—has become a popular approach for those looking to manage mood without losing clarity or motivation.

    RELATED: Is Cannabis Now The #1 Sleep Aid

    To be clear: cannabis doesn’t solve the root causes of anger. It won’t lower grocery prices or heal political divisions. What it can do is help some adults create a calmer internal state, making it easier to communicate, reflect, and respond thoughtfully rather than explosively.

    Used responsibly, cannabis may support anger management by helping people slow down, soften their reactions, and reconnect with a sense of balance. In a time when tempers are running high nationwide, a pause—however small—can make a meaningful difference.

    [ad_2]

    Anthony Washington

    Source link

  • Can You Mix Alcohol And Marijuana On NYE

    [ad_1]

    Can you mix alcohol and marijuana on NYE learn how to balance buzz vibes and next morning happiness

    New Year’s Eve is built for indulgence. Champagne and wine flows, cocktails shimmer, and for many adults, cannabis has become part of the celebration. But when the clock is ticking toward midnight, a common question bubbles up right alongside the champagne: can you mix alcohol and marijuana on NYE — and if so, how do you do it smartly?

    The short answer: yes, you can mix them — but how you do it matters more than ever.

    RELATED: 5 Ways Microdosing Cannabis Can Boost Work Performance

    Alcohol is a depressant which lowers inhibitions and speeds up decision-making. Cannabis, depending on the strain and dose, can either mellow you out or make sensations feel more intense. When combined, the effects don’t just stack — they amplify. That amplification can be delightful in small amounts… or uncomfortable if you overdo it.

    This is why seasoned celebrators add an additional golden rule: microdose first, sip second. This goes with the old saying of “beer before liquor, never been sicker; liquor before beer, you’re in the clear”.

    If you plan to combine cannabis and alcohol on New Year’s Eve, microdosing is your best friend. Instead of a full edible or a heavy pour, think less than you normally would — of both.

    • Edibles: Start with 2–2.5 mg of THC, not 10 mg.
    • Flower or vape: One or two small puffs, then wait.
    • Beverages: Choose low-ABV cocktails, wine spritzers, or beer instead of hard liquor.

    Give yourself at least 30–45 minutes before adding alcohol. Cannabis can increase alcohol absorption, meaning drinks may hit harder and faster than expected.

    There’s an old saying among experienced users: “Grass before glass, you’re on your… class.” Jokes aside, consuming cannabis before alcohol often leads to a smoother, more controlled experience. Doing it the other way around can increase dizziness and nausea — especially once edibles kick in.

    If you’ve already had a few drinks, it’s wise to skip cannabis entirely or keep it extremely light.

    One of the biggest myths is annabis prevents hangovers. It doesn’t — but it can help you drink less, which absolutely does.

    Smart strategies include:

    • Alternate every alcoholic drink with water or sparkling water
    • Eat before and during the evening (protein and healthy fats help)
    • Avoid sugary mixers late at night
    • Stop drinking at least an hour before midnight and switch to water or cannabis only

    Many people find cannabis encourages slower sipping, fewer drinks, and an earlier, happier bedtime — all wins for January 1st.

    RELATED: There’s No Known Cure For Arthritis, But Marijuana Works Wonders

    New Year’s Eve is about celebration, not excess. A low-dose edible paired with a glass of champagne, or a cannabis beverage alongside a light cocktail, can elevate the night without derailing it.

    The goal isn’t to get as altered as possible — it’s to feel good, stay social, remember the countdown, and wake up ready for the year ahead.

    If you choose to mix cannabis and alcohol this New Year’s Eve, do it intentionally. Start low, go slow, hydrate often, and listen to your body. When done thoughtfully, cannabis and alcohol can coexist — creating a relaxed, joyful, and surprisingly hangover-light way to ring in the New Year.

    [ad_2]

    Anthony Washington

    Source link

  • What Does the Public Think About Rescheduling Cannabis

    [ad_1]

    What does the public think about rescheduling cannabis in a post-prohibition era driven by data, not stigma.

    What does the public think about rescheduling cannabis? Long before federal officials formally moved to reschedule cannabis, they  had already made up their mind. According to a widely cited poll from Pew Research Center, 88% of Americans supported legal cannabis in some form—either for medical use, adult use, or both—prior to the rescheduling announcement. The overwhelming consensus set the stage for what many see as a long-overdue policy shift catching up with reality.

    RELATED: 5 Ways Microdosing Cannabis Can Boost Work Performance

    Post-rescheduling polling shows public opinion has only grown more confident, particularly around cannabis’s medical potential. A December 2025 survey from YouGov found more than three-quarters of U.S. adults believe cannabis has legitimate medical uses, while just a small minority disagreed. Notably, the poll also showed broad approval for rescheduling specifically because it allows expanded medical research—an issue which resonates across party lines.

    Another YouGov medical-focused poll reinforces the point. Large majorities said cannabis should be studied and made available as a treatment option, especially where conventional therapies fall short. This is not abstract support; it reflects lived experience. Veterans coping with PTSD consistently report medical cannabis can help manage anxiety, nightmares, and sleep disruption when traditional medications fail or cause harsh side effects. For many, rescheduling represents validation rather than experimentation.

    Patients with cancer, IBS, and chronic pain echo similar sentiments. Poll respondents frequently cite cannabis’s ability to ease nausea from chemotherapy, stimulate appetite, reduce inflammation, and improve sleep quality. Sleep, in particular, stands out as a near-universal concern—one where many Americans say cannabis has helped them fall asleep faster and stay asleep longer.

    RELATED: There’s No Known Cure For Arthritis, But Marijuana Works Wonders

    The impact extends beyond people. Everyday pet owners increasingly report using CBD products to calm anxious dogs during fireworks, ease joint pain in aging pets, and improve overall quality of life. While veterinarians urge careful dosing and further study, public acceptance of pet-focused CBD mirrors the broader shift toward viewing cannabis as a wellness tool rather than a cultural wedge issue.

    Taken together, these polls paint a clear picture. Americans are not debating whether cannabis belongs in modern medicine—they are asking how best to regulate, research, and responsibly use it. Rescheduling did not change public opinion; it aligned federal policy with a public already convinced cannabis can help real people, and even their pets, live better lives.

    [ad_2]

    Anthony Washington

    Source link

  • Feds Reveal Medical Cannabis Is Very Popular With The Disabled

    [ad_1]

    Feds reveal medical cannabis is very popular with the disabled, according to a new federal study examining pain relief, access and policy implications.

    In a move displaying the practical use of marijuana, the feds reveal medical cannabis is very popular with the disabled for a sound reason. A newly released federal study finds  Americans living with disabilities are increasingly using cannabis to manage pain, stress and other chronic symptoms, underscoring a growing gap between patient behavior and federal drug policy.

    The research, published in the Disability and Health Journal and funded by the National Institute on Disability, Independent Living, and Rehabilitation Research, draws on data from nearly 2,000 adults who self-identify as having a disability. About 22 percent of respondents reported current cannabis use, a rate notably higher than estimates for the general adult population.

    RELATED: 5 Ways Microdosing Cannabis Can Boost Work Performance

    Pain relief was the most frequently cited reason for use. More than 70 percent of participants said they use cannabis to manage pain, while roughly 60 percent reported using it to relax or reduce tension. Others cited relief from migraines, nausea, muscle spasms, sleep disturbances, seizures and mental health symptoms. Participants represented a wide range of disability types, including mobility, cognitive, vision, hearing, self-care and independent living limitations.

    Researchers note the data is self-reported and not nationally representative, with respondents skewing toward white, female and college-educated individuals. Still, the authors concluded cannabis use is prevalent across disability categories and warrants greater attention from public-health officials and policymakers.

    The findings arrive as the administration weighs whether to follow through on plans to reschedule cannabis under the Controlled Substances Act. Marijuana is currently classified as a Schedule I substance, a category reserved for drugs with no accepted medical use, despite growing evidence and widespread patient use. Moving cannabis to Schedule III would formally acknowledge its medical value and reduce barriers to research.

    For patients with disabilities, rescheduling is not an abstract policy issue. Federal classification affects everything from clinical research and physician guidance to affordability and access. Because cannabis remains federally restricted, doctors often lack clear guidelines, large-scale clinical trials remain limited, and insurance coverage is nonexistent. Patients are left navigating a patchwork of state rules while managing complex health needs.

    Advocates say the study highlights how policy has lagged behind reality. Millions of Americans with chronic conditions are already using cannabis as part of their care, often after conventional treatments failed or caused severe side effects. Many report turning to cannabis to reduce reliance on opioids, muscle relaxants and sleep medications, which can carry significant risks with long-term use.

    RELATED: There’s No Known Cure For Arthritis, But Marijuana Works Wonders

    Public-health experts warn continued delay has consequences. Without expanded research and standardized medical guidance, patients rely on trial and error rather than evidence-based care. For people with disabilities, who frequently manage multiple conditions at once, the uncertainty can be particularly harmful.

    Rescheduling would not legalize cannabis nationwide, but it would ease research restrictions, encourage clinical studies focused on disability-related conditions, and provide clearer guardrails for physicians and patients alike. Supporters argue it would move cannabis use out of the shadows and into a more accountable medical framework.

    As federal officials debate next steps, the study adds urgency to the discussion. For people living with daily pain and functional limitations, cannabis is not about recreation. It is about relief. The question now is whether federal policy will catch up with the patients already depending on it.

    [ad_2]

    Amy Hansen

    Source link

  • Smoking ‘a few harmless joints’ a month can hurt school performance, study says

    [ad_1]

    Any amount of regular marijuana use has a negative impact on teens’ academic performance, new research suggests.

    Using cannabis products just once a month was associated with worse grades and more emotional turmoil in teenagers, according to a study published Tuesday in the journal Pediatrics.

    MORE: Pennsylvania, New Jersey join lawsuit against federal rules restricting gender-affirming care for minors

    “A few ‘harmless’ joints can snowball into real academic consequences,” said Dr. Ryan Sultan, the study’s lead author. “Teens using it regularly often struggle to focus, miss school, and may lose interest in their future plans.”

    The findings come at a time when overall drug use has been at historically low levels among teens. Marijuana is the exception — with about 1 in 5 high schoolers reporting using cannabis, according to the National Center for Drug Abuse Statistics.

    At the same time, cannabis products have become much more potent in recent decades. Levels of THC, or Delta-9-tetrahydrocannabinol — which causes the mood-altering effects of the drug — rose from about 4% in 1995 to more than 16% in 2022. Most cannabis products available now have potencies over 20%, according to a recent report.

    For the new study, researchers analyzed data from more than 160,000 eighth-, 10th- and 12th-graders from national surveys conducted between 2018 and 2022. More than a quarter of the group said they used cannabis products, with 18% reporting near-daily use, 14% weekly use and 18% monthly use.

    Monthly users were twice as likely to do poorly in school and get into fights compared with students who did not use. Students who used cannabis products were also at higher risk for depression and anxiety.

    Students who used weed nearly every day were four times more likely to have low grades and to be disengaged from school, the study found.

    “A teenager’s brain is still developing the circuits for learning, self-control, and emotional regulation,” said Dr. Tim Becker, one of the study’s co-authors and a child and adolescent psychiatrist at NewYork-Presbyterian Westchester Behavioral Health. “Using cannabis, even casually, during these critical growth periods interferes with those processes and can derail normal development.”

    [ad_2]

    Courtenay Harris Bond

    Source link

  • Michigan cannabis group urges appeals court to intervene before 24% tax takes effect – Detroit Metro Times

    [ad_1]

    Michigan’s leading cannabis trade group is urging the Michigan Court of Appeals to immediately take up its legal challenge to a new 24% wholesale tax on marijuana, arguing the tax is unconstitutional and should be blocked before it takes effect on Jan. 1.

    The Michigan Cannabis Industry Association (MiCIA) filed an application for leave to appeal this week, seeking to overturn a Dec. 8 ruling by the Michigan Court of Claims that declined to stop the Legislature’s wholesale tax from going into effect while the case continues.

    “We stand by our belief that the Court of Claims did not make the right call when it issued an opinion that declined to block the Michigan Legislature’s unconstitutional 24% wholesale tax on cannabis from going into effect on New Year’s Day,” MiCIA spokesperson Rose Tantraphol said. “Our filing requests that the Court of Appeals take up our lawsuit, which we continue to believe is an exceptionally strong case on the merits.”

    The lawsuit argues lawmakers need a three-quarters supermajority to change voter-approved cannabis laws under the Michigan Constitution. When voters legalized recreational marijuana in 2018, they approved a 10% excise tax and 6% sales tax on retail cannabis sales. Any new or higher tax amounts to an amendment of that ballot measure and therefore needs a supermajority vote, MiCIA contends.

    The association sued in early October, seeking to eradicate the tax entirely and alleging lawmakers pushed it through using a “shell bill,” changing the measure’s purpose late in the legislative process in violation of the Michigan Constitution. 

    MiCIA is represented by attorneys from Honigman LLP and Dykema.

    In its Dec. 8 ruling, the Court of Claims rejected two of MiCIA’s constitutional arguments related to change of purpose and amendment by reference, but left a third issue unresolved. A hearing on that remaining issue is scheduled for Jan. 13.

    Because the case has not been fully resolved at the trial court level, MiCIA filed an application for leave to appeal, asking the Court of Appeals to intervene now.

    MiCIA argues the trial court erred by ruling against two of its claims and by declining to rule on the third, noting that all parties had agreed there were no factual disputes requiring further proceedings.

    The legislation, approved by a slim majority of Republican and Democratic lawmakers, was signed by Gov. Gretchen Whitmer, who supports the tax to pay for long-promised road repairs. 

    The state’s cannabis market has already been struggling from oversupply, falling prices, and shrinking profit margins. In November, the average retail price of recreational flower dropped to a record low of $59.79 an ounce, which is down from $512 when legal sales began in 2020. Total sales also began falling for the first time this year. 

    Industry leaders warn that adding a 24% wholesale tax will push Michigan’s legal cannabis prices close to those in California, where high taxes eroded parts of the legal market and drove consumers back underground.

    Tantraphol said delaying an appellate review would cause unnecessary harm to an industry already under financial strain.

    “The stakes are incredibly high,” she said. “The Michigan cannabis industry has been an economic engine for our state since voters legalized marijuana in 2018. Our industry has created 47,000 new jobs, pumped $331 million annually to schools, roads, and other public priorities through the 10% excise tax we collect, and generated $188 million in annual sales taxes. This unconstitutional move by the Legislature jeopardizes all of that.”

    Although the wholesale tax has not yet taken effect, Tantraphol said its impact is already being felt. One cannabis operation in Webberville has announced it will close, another business has told MiCIA it plans to shut down soon, and a company in the Upper Peninsula permanently laid off 61 workers last week.

    “Businesses will close and neighbors will lose jobs,” she said. “Cannabis businesses operate on thin margins, so allowing the 24% wholesale tax to go into effect will mean a lower volume of sales. The state’s own Senate Fiscal Agency predicts that due to market elasticity, total sales will decrease by about 14%.”

    MiCIA also warned the tax could drive consumers back to the illicit market.

    “The last thing the state should be doing is pushing Michiganders who are already feeling stretched financially into the illicit market,” Tantraphol said. “Let’s get this case to the Court of Appeals so that we can start to right this wrong.”

    In the same week the Michigan House approved the wholesale tax, California Gov. Gavin Newsom signed a bill to roll back a 25% tax increase on recreational cannabis. He approved the measure because the state’s high tax rates have forced thousands of legal businesses to shut down and drove residents to the unregulated market.


    [ad_2]

    Steve Neavling

    Source link

  • Can J.D. Vance stop a MAGA civil war?

    [ad_1]

    This week, editors Peter Suderman, Katherine Mangu-Ward, and Matt Welch are joined by Reason reporter Eric Boehm to discuss Turning Point USA’s AmericaFest and the GOP coalescing around Vice President J.D. Vance as President Donald Trump’s successor. They analyze Sen. Rand Paul’s (R–Ky.) opposition to endorsing Vance as the party’s next standard-bearer, and whether this signals he will challenge Vance for the nomination in 2028. Katherine also shares what it was like attending the conference, plus her debate over marijuana legalization as the Trump administration moves to reclassify marijuana from Schedule I to Schedule III.

    The editors then turn to the bipartisan backlash over the latest Jeffrey Epstein file release, in which more than 500 pages were completely redacted, prompting Reps. Thomas Massie (R–Ky.) and Ro Khanna (D–Calif.) to threaten charges of “inherent contempt” against Attorney General Pam Bondi. The panel also discusses the Trump administration’s seizure of additional Venezuelan oil tankers, plus the announcement of new military strikes in Syria. They dig into Minnesota’s widening welfare fraud scandal, and whether conservative media is using it to scapegoat Somali immigrants. A listener asks whether Christmas expands our “socialist bubble” of family and community and what that says about capitalism, socialism, and human nature.

     

    0:00—Debating marijuana at Turning Point USA

    4:10—J.D. Vance is the MAGA heir apparent

    14:47—Massie and Khanna react to Epstein file release

    25:14—U.S. foreign policy in Venezuela and Syria

    38:09—Listener question on socialism and Christmas

    47:59—Minnesota welfare fraud scandal

    1:01:28—Weekly cultural recommendations

     

    Mentioned in This Podcast

    “Cannavictory,” by Liz Wolfe

    “Trump Orders the ‘Expeditious’ Reclassification of Marijuana,” by Jacob Sullum

    “Heritage Foundation Undergoes Mass Staff Exodus as Cracks Open on the New Right,” by Stephanie Slade

    “Epstein Wanted To Turn His Island Into a Resort for Paying Customers,” by Matthew Petti

    “Oil Tanker Seized,” by Liz Wolfe

    “If the Syrian War Is Over, Why Are Americans Still Getting Killed in Syria?” by Matthew Petti

    “Trump’s Somali Insults Are a Disgrace,” by Steven Greenhut

    “The Real Villain in Minnesota’s $1.5 Billion Fraud Scandal Isn’t Somalis—It’s the Feds,” by Jack Nicastro

    “Medicare Whac-A-Mole,” by Peter Suderman

    “What We Get Wrong About the American Revolution,” by Nick Gillespie

    “Avatar: Fire and Ash Is Part Spectacle, Part Retread,” by Peter Suderman

    [ad_2]

    Peter Suderman

    Source link

  • Has Cannabis Claimed Its First Alcohol Victim

    [ad_1]

    Has cannabis claimed its first alcohol victim? Jim Beam’s production pause may reveal shifting drinking trends.

    Cannabis has surged in popularity across the United States in recent years, cutting across age groups from older medicinal users to younger adults who increasingly embrace it for recreational and wellness purposes. As cultural attitudes shift and legal access expands — now with major moves at the federal level to reschedule cannabis — traditional alcohol consumption patterns are visibly changing too. Emerging data show younger generations, especially Generation Z, are drinking far less than their predecessors, opting instead for alternatives like cannabis or choosing moderation for health and lifestyle reasons. Drinking rates among adults under 35 have steadily declined over the past two decades, underscoring a generational shift away from habitual alcohol use.  And the question is has cannabis claimed its first alcohol victim?

    RELATED: 5 Ways Microdosing Cannabis Can Boost Work Performance

    At the federal level, the United States is on the brink of historic change in how it views and regulates cannabis. The current administration has taken formal steps toward rescheduling marijuana, acknowledging its accepted medical uses and easing long-standing federal restrictions. While rescheduling does not equate to full legalization, it would reduce regulatory barriers, expand medical research opportunities, and significantly alter the financial and operational landscape for the legal cannabis industry. These moves reflect a broader cultural shift in which cannabis is increasingly normalized, while alcohol faces mounting competition for consumer attention and dollars.

    Photo by 2H Media via Unsplash

    Those changing preferences are now rippling through the alcohol industry. A striking example emerged with the announcement Jim Beam will pause production at its flagship distillery in Clermont, Kentucky, beginning in 2026. The move was made by parent company Suntory Global Spirits as part of a strategic adjustment to address slowing demand and an oversupply of aging bourbon barrels. While bottling, warehousing, and visitor operations will continue, a full production pause at one of the most iconic bourbon sites in the world is an unusually strong signal the industry is recalibrating.

    Multiple pressures are converging at once. Kentucky warehouses are holding record levels of bourbon, domestic spirits consumption has softened, and international sales have been hit hard by tariffs which have significantly damaged export markets. Canada, historically one of the most important destinations for American whiskey, has been particularly affected, with higher costs and retaliatory trade measures sharply reducing demand. Together, these forces have made it harder for even legacy brands to justify uninterrupted production.

    RELATED: Marijuana Use And Guy’s Member

    To fully grasp the significance, it helps to revisit the history of Jim Beam itself. Founded in 1795 when Jacob Beam sold his first barrels of whiskey in Kentucky, the brand is one of the oldest continuously produced bourbons in the world. Jim Beam survived Prohibition, rebuilt under James Beauregard “Jim” Beam in the 1930s, and went on to become a global symbol of American whiskey.

    At the height of its popularity in the late 20th and early 21st centuries, Jim Beam was ubiquitous — a staple on back bars, a fixture at family gatherings, and a cultural shorthand for bourbon itself. While the brand remains strong, the current pause suggests a changing landscape where tradition alone is no longer enough. Whether cannabis has claimed its first true alcohol casualty remains up for debate, but the shift in American consumption habits is no longer theoretical — it is playing out in real time, barrel by barrel.

    [ad_2]

    Anthony Washington

    Source link

  • Which Of These Two Industries Contribute More To The Economy

    [ad_1]

    The Feds support shipbuilding but compared to marijuana which of these two industries contribute more to the economy.

    In recent months, the current presidential administration has made shipbuilding a visible national priority, citing economic security, defense readiness, and the need to rebuild American industrial capacity. Federal speeches, policy directives, and funding discussions have elevated shipbuilding as a symbol of manufacturing revival. At the same time, the cannabis industry continues to receive cautious, uneven federal attention. While it has moved forward on rescheduling, Mmarijuana remains illegal at the federal level. Reform legislation advances slowly despite strong public support. The contrast between robust federal backing for shipbuilding and the tepid, uncertain approach toward cannabis shapes a broader debate over which of these two industries contribute more to the economy?

    RELATED: What Does Cannabis Rescheduling Mean

    Measured purely by scale, the two industries look very different. U.S. shipbuilding today is a relatively small and highly specialized sector. The country currently produces roughly three large commercial ships per year, with shipyards concentrated in a handful of coastal states. According to commonly cited labor estimates, including those referenced by industry analysts and public employment data, the average shipbuilding salary is about $59,000 annually. While some skilled welders, engineers, and managers earn more, an average reflecting a workforce closer to the national median wage than many assume.

    Photo by smodj/Getty Images

    The cannabis industry, by contrast, operates at far greater scale. Legal marijuana supports more than 400,000 jobs nationwide across cultivation, manufacturing, retail, compliance, logistics, and technology. Industry revenues exceed $30 billion annually, with legal sales spread across more than half the states. Average wages vary widely, but many full-time cannabis workers earn salaries comparable to shipbuilding employees, particularly in regulated states with established markets.

    One of the most important economic differences is time. Even with full federal support, shipbuilding cannot expand quickly. Building new shipyards, modernizing facilities, training skilled labor, and securing supply chains takes years, often decades. Workforce pipelines require long-term investment in apprenticeships and technical education, and new production capacity cannot be switched on quickly. Economic benefits from expanded shipbuilding, while real, will be gradual and regionally concentrated.

    Cannabis growth follows a very different pattern. Because the industry is already operating in dozens of states, economic expansion can happen rapidly when regulations change. New licenses, retail stores, and cultivation sites can open in months, not years. Tax revenue flows immediately once sales begin, and employment grows alongside local demand. This speed matters at a time when states are looking for near-term economic relief and job creation.

    RELATED: Who Is Rep. Andy Harris And Why Does He Hate Cannabis

    Another key distinction is ownership. Shipbuilding is dominated by large contractors and defense-linked firms. Cannabis, on the other hand, has supported thousands of small and mid-sized businesses. Many dispensaries, farms, manufacturers, and ancillary companies are locally owned, creating opportunities for entrepreneurs and keeping profits within communities. These mom-and-pop operations contribute to neighborhood employment, commercial real estate occupancy, and local tax bases in ways large industrial projects often do not.

    From a tax perspective, cannabis already delivers significant returns to state governments through excise taxes, sales taxes, and licensing fees, funding schools, infrastructure, and public health programs. Shipbuilding generates tax revenue primarily through payroll and corporate activity, but its overall footprint is smaller due to limited production volume.

    Shipbuilding remains strategically important and worthy of investment, particularly for national security and industrial resilience. But economically, cannabis already touches more workers, more states, and more local economies, despite operating under federal restrictions. The comparison suggests while shipbuilding represents a long-term industrial project, cannabis is a functioning, revenue-generating sector whose economic contributions are already being felt across much of the country.

    [ad_2]

    Anthony Washington

    Source link